logo

For the Inventor, By the Inventor

Belle Mead, NJ, United States of America

Hong Gao

This inventor holds 8 USPTO granted patents. Top assignee: Wyeth. Active years: 2003-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hong Gao. Retrieved from https://idiyas.com/inventor/hong-gao-8vdd4il5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Plainsboro, NJ (US) (2003)
  • Belle Mead, NJ (US) (2004 - 2010)

Company Filing History:

goldMedal8 out of 1,309 
 
Wyeth
 patents

Years Active: 2003-2010

Loading Chart...
8 patents (USPTO):Explore Patents
1. 7728155 - Dihydrobenzofuranyl alkanamines and methods for using same as cns agents (2010-06-01),
2. 7435837 - Dihydrobenzofuranyl alkanamine derivatives and methods for using same (2008-10-14),
3. 7368477 - Benzofuranyl alkanamine derivatives and uses thereof (2008-05-06),
4. 7365095 - Chromane and chromene derivatives and uses thereof (2008-04-29),
5. 7012089 - [1,4]Diazocino[7,8,1-hi]indole derivatives as antipsychotic and antiobesity agents (2006-03-14),
6. 6919334 - Antidepressant azaheterocyclymethyl derivatives of 4,5-dihydroimidazo[1,4,5-de][1,4]benzoxazine (2005-07-19),
7. 6706736 - Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused-[1,4]-benzodioxans (2004-03-16),
8. 6552049 - Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused-[1,4]-benzodioxans (2003-04-22),

Title: **Innovations of Hong Gao: Pioneering CNS Agents**

Introduction

Hong Gao, an accomplished inventor based in Belle Mead, New Jersey, has made significant contributions to the field of pharmacology with a total of eight patents to her name. Her research primarily focuses on compounds that can be used to treat central nervous system disorders, particularly schizophrenia. Through her innovative work, she has advanced the understanding and treatment options available for these complex conditions.

Latest Patents

Among her latest patents, Hong Gao has developed compounds known as dihydrobenzofuranyl alkanamines, which function as agonists and partial agonists of the 2C subtype of brain serotonin receptors. These compounds and their pharmaceutically acceptable salts have shown potential in treating a variety of central nervous system disorders. Both patents notably emphasize the significance of these compounds in addressing conditions like schizophrenia, highlighting their therapeutic relevance and innovative approach.

Career Highlights

Hong Gao’s impressive career is closely associated with her work at Wyeth, where she has collaborated with some of the leading experts in the field. Her dedication to advancing CNS agents has positioned her as a key figure in pharmaceutical innovation, contributing significantly to the progress of treatments that may improve patient outcomes.

Collaborations

Throughout her career, Hong Gao has had the opportunity to work alongside esteemed colleagues such as Gary Paul Stack and Jonathan Laird Gross. These collaborations not only fostered her professional growth but also facilitated the exchange of ideas that often leads to groundbreaking innovations in the realm of medicine.

Conclusion

In summary, Hong Gao exemplifies the spirit of innovation within the pharmaceutical industry. Her extensive work on dihydrobenzofuranyl alkanamines and her continued research into CNS agents reflect her commitment to improving therapeutic options for individuals with mental health disorders. As she continues to push the boundaries of medical science, Hong Gao remains a prominent figure in the patent landscape, inspiring future generations of inventors and researchers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…